VolitionRx Ltd
VNRX
29 hedge funds and large institutions have $18.2M invested in VolitionRx Ltd in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
52% more capital invested
Capital invested by funds: $12M → $18.2M (+$6.25M)
16% more funds holding
Funds holding: 25 → 29 (+4)
0.07% more ownership
Funds ownership: 1.09% → 1.16% (+0.07%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$833K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$506K |
| 3 |
AC
Armistice Capital
New York
|
+$158K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$107K |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$37.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$45.1K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$18.4K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$12.2K |
| 4 |
Millennium Management
New York
|
-$6.17K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.07K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
BNP Paribas Financial Markets
Paris,
France
| $201 | – | – | – |
|
|
AF
27
Allworth Financial
Folsom,
California
| $152 | – | – | – |
|
|
SS
28
SBI Securities
Tokyo,
Japan
| $81 | +$55 | +5 | New |
|
|
XT
29
XTX Topco
George Town,
Cayman Islands
| – | -$18.4K | -1,614 | Closed |
|
|
TSS
30
Two Sigma Securities
New York
| – | -$12.2K | -1,074 | Closed |
|
|
31
Millennium Management
New York
| – | -$6.17K | -541 | Closed |
|
|
HFM
32
Hartford Financial Management
Hartford,
Connecticut
| – | -$2.85K | -250 | Closed |
|
33
Fidelity Investments
Boston,
Massachusetts
| – | -$171 | -15 | Closed |
|
34
Simplex Trading
Chicago,
Illinois
| – | +$55 | +5 | +19% |
|
VNRX Hedge Fund Activity: Q2 2025 in Review
29 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q2 2025, worth a combined $18.2M — up 52% from $12M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new VNRX positions and 5 closed out — a net gain of 4 holders — while 7 added to existing stakes and 4 trimmed.
The largest buyer was Lagoda Investment Management, adding an estimated $833K. The largest seller was UBS Group, cutting an estimated $45.1K.
- 29 institutional investors held VolitionRx Ltd (VNRX) as of Q2 2025, up from 25 in Q1 2025.
- Funds reported $18.2M of VolitionRx Ltd stock for Q2 2025, up 52% quarter-over-quarter.
- 9 funds opened new VolitionRx Ltd positions in Q2 2025 and 5 closed out, a net change of +4 holders.
- The largest VolitionRx Ltd buyer in Q2 2025 was Lagoda Investment Management, an estimated $833K added.
- The largest VolitionRx Ltd seller in Q2 2025 was UBS Group, an estimated $45.1K sold.
Based on aggregated 13F filings for Q2 2025.